Treatment Binder Codes
A treatment binder code is a shortcode for a group of "standard" handouts. By using the code, the tool will auto-select all the handouts included with that code.
Below is a list of currently available Treatment Binder Codes. Click on a code to view more details on what is included.
Don't see what you are looking for? Submit a request for a new code!
How do I use the codes?
- Use the disease filter to jump to codes for that cancer type.
- Find the code that matches the regimen or treatment your patient is getting.
- You can click on the description to view all the handouts included in that standard binder code.
- You can then:
- use the "build" button to jump back to the builder page and auto-select the handouts for that code.
- OR you can make note of the code and type it into the standard codes box on the binder builder page.
- You can then add or remove any handouts and use the download/build button to create the binder.
**If you are using a white label/branded binder or an EPIC tool, you cannot use the "build" button. Please copy the code into your tool.
Brain
Breast
- Breast - Ado-trastuzumab emtansine
- Breast - Anastrozole
- Breast - carbo, taxol, pembro, cytoxan, dox
- Breast - Carboplatin
- Breast - Cisplatin
- Breast - Cytoxan Oral
- Breast - Docetaxel
- Breast - Docetaxel and Cyclophosphamide
- Breast - Docetaxel, Carboplatin
- Breast - Docetaxel, Carboplatin, Trastuzumab
- Breast - Doxo, Cytoxan
- Breast - Doxo, Cytoxan, Taxol
- Breast - Doxo, Cytoxan, Taxol + Keytruda
- Breast - Everolimus
- Breast - Exemestane
- Breast - Fulvestrant
- Breast - Gefitinib
- Breast - Gemcitabine
- Breast - Gemcitabine and Carboplatin
- Breast - Gemcitabine and Docetaxel
- Breast - Herceptin
- Breast - High-dose MTX, leucovorin
- Breast - Letrozole
- Breast - Leuprolide
- Breast - Megestrol
- Breast - Navelbine
- Breast - Paclitaxel
- Breast - Paclitaxel, Protein Bound
- Breast - Palbociclib, Letrozole
- Breast - Pertuzumab
- Breast - Radiation 2
- Breast - Rads
- Breast - RCVP
- Breast - Tamoxifen
- Breast - Taxol and Gemzar
Endocrine/NET
GU
- Bladder - Atezolizumab
- Bladder - Carbo/Etoposide
- Bladder - Carboplatin
- Bladder - Cis, Gem
- Bladder - Enfortumab
- Bladder - Gemcitabine
- Bladder - Gemcitabine and Carboplatin
- Bladder - Paclitaxel, Protein Bound
- Bladder - Sacituzumab
- Bladder - Taxol and Gemzar
- Bladder/Urothelial - MVAC
- GU - Nivolumab, Ipilimumab
- GU - Radiation
- Immunotherapy - Nivolumab
- Kidney - Axitinib
- Kidney - Bevacizumab
- Kidney - Nivolumab
- Kidney - Pazopanib
- Kidney - Sorafenib
- Kidney - Sunitinib
- Pelvis - Rads
- Renal/Urothelial - Pembrolizumab
- Testicular - BEP
- Testicular - RCVP
- Testicular/Bladder - Cisplatin
Gyn
- Cisplatin plus Radiation Therapy
- Endometrial - Megestrol
- GYN - BEP
- Gyn - Carbo, Etoposide
- Gyn - Carbo, Paclitaxel
- GYN - Cisplatin
- GYN - Cis, Gem
- GYN - Cisplatin, Paclitaxel, Bevacizumab
- Gyn - Docetaxel, Carboplatin
- Gyn - Dox Liposomal
- GYN - Gemcitabine
- Gyn - Gemcitabine and Carboplatin
- Gyn - Niraparib
- GYN - Paclitaxel
- Gyn - Paclitaxel, Protein Bound
- GYN - Pembrolizumab
- GYN - Pembrolizumab, Lenvima
- Gyn - RCVP
- Gyn - Topotecan
- Gynecologic Cancers - Radiation (Cylinder)
- Gynecologic Cancers - Radiation (Interstitial)
- Gynecologic Cancers - Radiation (T&O)
- Immunotherapy - Nivolumab
- Ovarian - Cytoxan Oral
- Ovarian - Hydrea
- Ovarian - Navelbine
- Ovarian - Olaparib
- Ovarian - Rucaparib
Head & Neck
- Cisplatin plus Radiation Therapy
- H&N - Dox Liposomal
- H&N - Nivolumab, Ipilimumab
- Head & Neck - Cisplatin
- Head & Neck - Cisplatin plus RT
- Head & Neck - Docetaxel
- Head & Neck - High-dose MTX, leucovorin
- Head & Neck - Hydrea
- Head & Neck - Nivolumab
- Head & Neck - Pembrolizumab
- Head & Neck - Radiation 2
- Head and Neck - Carboplatin
- Head and Neck - Docetaxel, Cisplatin, 5FU
- Head and Neck - Rads
- Immunotherapy - Nivolumab
Heme
- Heme - Ibrutinib
- Immunotherapy - Nivolumab
- Leukemia - Acalabrutinib
- Leukemia - Ara-C, Dauno
- Leukemia - Azacitidine, Venetoclax
- Leukemia - Bosutinib
- Leukemia - Cytoxan Oral
- Leukemia - Chlorambucil, Ofatumumab
- Leukemia - Cladribine, Ara-C, Mito
- Leukemia - Dasatinib
- Leukemia - HyperCVAD
- Leukemia - Idelalisib
- Leukemia - Imatinib
- Leukemia - Midostaurin
- Leukemia - Nilotinib
- Leukemia - Obintuzumab
- Leukemia - Oral MTX
- Leukemia - Oral MTX, 6-MP, Dex, Dasatinib
- Leukemia - Oral MTX, Mercaptopurine, Dex
- Leukemia - Ponatinib
- Leukemia- Hydrea
- Leukemia/Lymphoma - Bendamustine, Rituxan
- Leukemia/Lymphoma - Fludarabine, Rituxan
- Leukemia/Lymphoma - High Dose Ara-C
- Leukemia/Lymphoma - High-dose MTX, leucovorin
- Leukemia/Lymphoma - R-MVP
- Leukemia/Lymphoma - RICE
- Leukemia/Lymphoma - Rituxan
- Leukemia/Lymphoma - Venetoclax
- Leukemia/Lymphoma/Myeloma - RCVP
- Lymphoma - Bedamustine, Rituxan
- Lymphoma - Dex, Cytarabine, Cisplatin
- Lymphoma - Doxo, Bleo, Vinblastine, Dacarbazine
- Lymphoma - Etop, Pred, Vinc, Cytoxan, Doxo, Rituxan
- Lymphoma - Nivolumab
- Lymphoma - Pembrolizumab
- Lymphoma - RCHOP
- Lymphoma/Myeloma - Cisplatin
- Lymphoma/Myeloma - Etop, Solu-Medrol, Ara-C, Cisplat
- MDS - Azacitidine
- Mulitple Myeloma - Teclistamab-cqyv
- Multiple Myeloma - Carfilzomib
- Multiple Myeloma - Daratumumab and Hyaluronidase
- Multiple Myeloma - Daratumumab, Cyclophosphamide, Bortezomib, Dexamethasone
- Multiple Myeloma - Radiation
- Multiple Myeloma - Talquetamab
- Myeloma - Bortezomib, Dexamethasone
- Myeloma - Carfilzomib and Dexamethasone
- Myeloma - Cytoxan, Velcade, Dex, Zometa
- Myeloma - Daratumumab
- Myeloma - Daratumumab, Dexamethasone
- Myeloma - Daratumumab, Pomalidomide, Dexamethasone
- Myeloma - Dox Liposomal
- Myeloma - Ixazomib
- Myeloma - Ixazomib, Dex, Lanalidomide
- Myeloma - Ixazomib, Dexamethasone
- Myeloma - Lenalidomide
- Myeloma - Lenalidomide, Dex
- Myeloma - Panobinostat, Bortezomib, Dex
- Myeloma - Panobinostat, Revlimid, Dex
- Myeloma - Pomalidomide
- Myeloma - Pomalidomide, Bortezomib, Dex
- Myeloma - Pomalidomide, Dexamethasone
- Myeloma - Revlimid, Velcade, Dex, Zometa
- Myeloma - Thalidomide
Lower GI
- Anal - Radiation
- Anal - Radiation EOT
- Colorectal - Bevacizumab
- Colorectal - Bevacizumab, Capecitabine, Oxaliplatin
- Colorectal - Bevacizumab, Oxaliplatin, Leucovorin, Fluorouracil
- Colorectal - Cetuximab
- Colorectal - Capecitabine, Oxaliplatin
- Colorectal - Encorafenib, Cetuximab
- Colorectal - Irinotecan
- Colorectal - Irinotecan, Leuco, 5FU
- Colorectal - Lonsurf, Bevacizumab
- Colorectal - Nivolumab
- Colorectal - Oxaliplatin, Leucovorin, Fluorouracil
- Colorectal - Panitumumab
- Colorectal - Panitumumab, Irinotecan, Leucovorin, Fluorouracil
- Colorectal - Pembrolizumab
- Colorectal - Regorafenib
- Colorectal - Trifluridine and Tipiracil
- CRC - 5FU, Leucovorin
- Immunotherapy - Nivolumab
- Liver - Dox Liposomal
- Liver - Regorafenib
- Lower GI - Nivolumab, Ipilimumab
- Pelvis - Rads
- Rectal - Radiation
- Rectal - Radiation EOT
Lung
- Immunotherapy - Nivolumab
- Lung - Afatinib
- Lung - Atezolizumab
- Lung - Bevacizumab
- Lung - Carbo, Etoposide
- Lung - Carbo, Etoposide, Atezolizumab
- Lung - Carbo/Pem/Pem
- Lung - Carbo/Pemetrexed
- Lung - Gemcitabine and Carboplatin
- Lung - Carboplatin, Cisplatin
- Lung - Carboplatin, Paclitaxel
- Lung - Carboplatin, Paclitaxel (Abraxane), Pembrolizumab
- Lung - Carboplatin, Paclitaxel, Pembrolizumab
- Lung - Cisplatin, Etoposide
- Lung - Cisplatin/Pemetrexed
- Lung - Crizotinib
- Lung - Docetaxel
- Lung - Docetaxel, Carboplatin
- Lung - Dox Liposomal
- Lung - Durvalumab
- Lung - Erlotinib
- Lung - Everolimus
- Lung - Gefitinib
- Lung - Gemcitabine
- Lung - Gemcitabine and Docetaxel
- Lung - Gemcitabine, Cisplatin
- Lung - High-dose MTX, leucovorin
- Lung - Navelbine
- Lung - Nivolumab
- Lung - Nivolumab, Ipilimumab
- Lung - Paclitaxel
- Lung - Paclitaxel, Protein Bound
- Lung - Pemetrexed
- Lung - Pembrolizumab, Pemetrexed, Carboplatin
- Lung - Rads
- Lung - RCVP
- Lung - Tarlatamab-dlle
- Lung - Topotecan
- Lung Cancer Nutrition
- Lung/Mesothelioma - Cis, Gem
- Lung/Mesothelioma - Cisplatin
Lymphoma
- Lymphoma - Cytoxan Oral
- Lymphoma - Dox Liposomal
- Lymphoma - Epcoritamab-bysp
- Lymphoma - Fludarabine and Rituxan
- Lymphoma - Lenalidomide, Rituxan
- Lymphoma - Lomustine
- Lymphoma - MTX, Temodar, Rituxan
- Lymphoma - Nivolumab, Ipilimumab
- Lymphoma - Obintuzumab
- Lymphoma - Rituxan, Cytoxan, Vincristine, Prednisone
- Lymphoma - Rituxan, MTX, Leucovorin, Procarbazine, Vincristine
- Lymphoma - Temodar, MTX, Rituxan, Etop, High-dose Ara-C
Non-Oncology
Prostate
Psychosocial
Sarcoma
Skin
Upper GI
- Biliary Tract/Pancreatic - Cis, Gem
- Esoph - Rads
- Esoph - Rads1
- Esoph/Liver/Stomach/GEJunction - Pembrolizumab
- Esoph/Stomach - Cisplatin
- Esophageal - Carboplatin
- Esophageal - Nivolumab
- Esophageal - Paclitaxel, Protein Bound
- Liver - Atezolizumab
- Liver - Nivolumab
- Liver - Radiation1
- Liver - Rads
- Liver - Sorafenib
- Pancreas - Everolimus
- Pancreas - FOLFIRINOX
- Pancreatic - Gemcitabine
- Pancreatic - Gemcitabine and Capecitabine
- Pancreatic - Paclitaxel, Protein Bound
- Pancreatic - Paclitaxel, Protein Bound and Gemcitabine
- Pancreatic - RAD1
- Pancreatic - Rads
- Stomach - 5FU, Leuco, Oxali, Doce
- Stomach - Cisplatin, Capecitabine
- Stomach - Docetaxel
- Stomach - Docetaxel, Cisplatin, 5FU
- Stomach - Dox Liposomal
- Stomach - Everolimus
- Stomach - High-dose MTX, leucovorin
- UGI - Nivolumab, Ipilimumab
- Upper GI - Herceptin